A Systematic Strategy of Combinational Blow for Overcoming Cascade Drug Resistance via NIR‐Light‐Triggered Hyperthermia

Lingna Wang,Yingjie Yu,Dengshuai Wei,Lingpu Zhang,Xiaoyan Zhang,Guanxin Zhang,Dan Ding,Haihua Xiao,Deqing Zhang

DOI: https://doi.org/10.1002/adma.202100599

IF: 29.4

2021-04-08

Advanced Materials

Abstract:A systematic combination strategy is proposed for overcoming cisplatin resistance using near-infrared (NIR)-light-triggered hyperthermia. A new photothermal polymer DAP-F is complexed with a reduction-sensitive amphiphilic polymer P1 to form F-NPs with photothermal effect. Subsequently, to build the final nanosystem F-Pt-NPs, F-NPs are combined with Pt-NPs, which are obtained by encapsulating a Pt(IV) prodrug with P1. Mild hyperthermia (43 °C), generated from F-Pt-NPs induced by an 808 nm NIR laser, have various effects such as: i) enhancing the cellular membrane permeability to promote the uptake of drugs; ii) activating cisplatin by accelerating the glutathione consumption; iii) increasing the Pt-DNA adducts formation and possibly the formation of a portion of irreparable Pt-DNA interstrand crosslinks, thereby inhibiting the repair of DNA. In vitro, it is found that even on cisplatin-resistant A549DDP cells, the IC₅₀ of F-Pt-NPs (43 °C) is only 7.0 × 10^-6 m Pt mL^-1 . In vivo, on a patient-derived xenograft model of multidrug resistant lung cancer, the efficacy of the F-Pt-NPs (43 °C) treatment group shows a tumor inhibition rate of 94%. Taken together, here, an important perspective of resolving cascade drug resistance with the assistance of mild hyperthermia triggered by NIR light is presented, which can be of great significance for clinic translation.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology

What problem does this paper attempt to address?

This paper aims to solve the multi - step cascade drug resistance (CDR) problem encountered by the chemotherapeutic drug cisplatin in cancer treatment. Specifically, the resistance mechanism of cisplatin involves multiple steps, including decreased intracellular uptake, increased glutathione (GSH) detoxification, and inhibition of cisplatin - DNA adduct formation, etc. Most of the existing strategies only target one or two specific drug - resistant processes while ignoring the overall battle. Therefore, the researchers proposed a new systematic combination strategy, which comprehensively targets the key factors of cisplatin resistance through mild hyperthermia triggered by near - infrared light (NIR - light), rather than just a single step, in order to achieve unexpected effects and ultimately overcome cisplatin resistance.

The core of the research lies in the development of a nanosystem named F - Pt - NPs, which is composed of F - NPs with photothermal effect and Pt - NPs encapsulating cisplatin prodrug. The experimental results show that this nanosystem can significantly improve the anticancer effect on cisplatin - resistant A549DDP cells under the condition of mild hyperthermia at 43 °C, and its half - maximal inhibitory concentration (IC50) is only 7.0 × 10^−6 m Pt/mL. In addition, in the patient - derived xenograft model of multi - drug - resistant lung cancer (PDXMDR), the tumor inhibition rate in the F - Pt - NPs (43 °C) treatment group reached 94%, indicating the great potential of this strategy in clinical translation.

In general, this study provides a new method to overcome cisplatin cascade drug resistance by using mild hyperthermia triggered by NIR light, which is of great significance for improving the therapeutic effect of cisplatin.